• Company
• Clinical trials for K-pharma's new lung fibrosis drugs
• by Son, Hyung-Min Jul 31, 2024 05:51am

• Company
• Samsung Bioepis launches Stelara biosimilar Pyzchiva in EU
• by Hwang, Byung-woo Jul 30, 2024 05:52am

• Opinion
• [Reporter's View] Insight into reimb of high-priced drugs
• by Eo, Yun-Ho Jul 30, 2024 05:52am

• Company
• First patient dosing with Pluvicto imminent in Korea
• by Moon, sunh-ho Jul 30, 2024 05:52am

• Opinion
• [Reporter's View] Pharmas rethink bio venture investments
• by Lee, Seok-Jun Jul 30, 2024 05:51am

• Policy
• GSK receives administrative disposition in KOR
• by Lee, Hye-Kyung Jul 30, 2024 05:51am

• Company
• Pfizer's MM drug Elerexfio seeks reimb in KOR
• by Eo, Yun-Ho Jul 29, 2024 05:48am

• Company
• Eylea biosimilar 'Afilivu' will be prescribed
• by Eo, Yun-Ho Jul 29, 2024 05:48am

• Company
• GC accelerates global entry…targets China and Vietnam
• by Her, sung-kyu Jul 29, 2024 05:48am

• Policy
• Daewoong secures generic Xigduo through a transfer
• by Lee, Tak-Sun Jul 29, 2024 05:48am